See more : Mitsubishi Estate Co., Ltd. (MITEY) Income Statement Analysis – Financial Results
Complete financial analysis of Hanmi Science Co., Ltd. (008930.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hanmi Science Co., Ltd., a leading company in the Medical – Distribution industry within the Healthcare sector.
- RDB Realty & Infrastructure Limited (RDBRIL.BO) Income Statement Analysis – Financial Results
- Diamond Power Infrastructure Limited (DIACABS.NS) Income Statement Analysis – Financial Results
- Sartorius Stedim Biotech S.A. (SDMHF) Income Statement Analysis – Financial Results
- Luminex Corporation (LMNX) Income Statement Analysis – Financial Results
- Israel Land Development – Urban Renewal Ltd (ILDR.TA) Income Statement Analysis – Financial Results
Hanmi Science Co., Ltd. (008930.KS)
About Hanmi Science Co., Ltd.
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer. The company also offers drug substances, general medicines, health functional foods, and nutrition and health products and services. In addition, it operates an online pharmacy; and offers pharmaceutical management automation systems. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is based in Seoul, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,247.91B | 1,046.05B | 950.16B | 857.38B | 816.62B | 708.00B | 652.32B | 665.28B | 776.22B | 532.60B | 219.86B | 19.65B | 16.81B | 641.47B | 689.96B | 606.80B | 531.40B |
| Cost of Revenue | 982.80B | 944.35B | 817.39B | 736.67B | 708.29B | 615.59B | 624.02B | 637.61B | 619.54B | 1.49B | 1.46B | 0.00 | 0.00 | 274.51B | 269.85B | 216.34B | 174.55B |
| Gross Profit | 265.10B | 101.70B | 132.77B | 120.72B | 108.33B | 92.41B | 28.31B | 27.68B | 156.68B | 531.11B | 218.41B | 19.65B | 16.81B | 366.96B | 420.11B | 390.46B | 356.85B |
| Gross Profit Ratio | 21.24% | 9.72% | 13.97% | 14.08% | 13.27% | 13.05% | 4.34% | 4.16% | 20.18% | 99.72% | 99.34% | 100.00% | 100.00% | 57.21% | 60.89% | 64.35% | 67.15% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 60.84B | 49.30B | 34.67B | 36.77B |
| General & Administrative | 38.53B | 897.84B | 10.88B | 9.82B | 9.32B | 10.84B | 572.13B | 590.91B | 569.59B | 475.69B | 171.12B | 3.36B | 3.23B | 87.31B | 86.59B | 86.89B | 69.96B |
| Selling & Marketing | 67.83B | 57.16B | 41.83B | 37.73B | 35.56B | 28.32B | 26.30B | 24.56B | 21.52B | 17.88B | 12.53B | 2.62B | 1.87B | 88.00B | 85.38B | 66.38B | 57.18B |
| SG&A | 106.37B | 955.00B | 52.71B | 47.54B | 44.88B | 39.16B | 598.44B | 615.47B | 591.11B | 493.57B | 183.65B | 5.99B | 5.09B | 175.32B | 171.97B | 153.27B | 127.14B |
| Other Expenses | 0.00 | 62.95B | 52.47B | 49.33B | 48.75B | 43.70B | -4.15B | -10.19B | 18.21B | 3.30B | 76.86M | 991.04M | 8.41B | 1.15B | 5.90B | 1.40B | 123.22M |
| Operating Expenses | 140.64B | 1,017.94B | 105.18B | 96.87B | 93.63B | 82.87B | 638.35B | 650.22B | 629.56B | 523.59B | 213.57B | 16.03B | 13.51B | 362.84B | 347.12B | 308.77B | 276.04B |
| Cost & Expenses | 1,123.44B | 1,017.94B | 922.57B | 833.54B | 801.92B | 698.45B | 638.35B | 650.22B | 629.56B | 523.59B | 213.57B | 16.03B | 13.51B | 637.36B | 616.97B | 525.11B | 450.59B |
| Interest Income | 601.09M | 164.12M | 94.61M | 130.51M | 235.35M | 321.78M | 838.82M | 1.40B | 1.10B | 606.39M | 433.89M | 262.71M | 350.13M | 1.00B | 820.42M | 1.30B | 1.27B |
| Interest Expense | 10.16B | 3.69B | 1.79B | 1.70B | 1.73B | 1.10B | 1.22B | 1.38B | 2.65B | 2.96B | 1.35B | 1.39B | 828.85M | 15.25B | 15.26B | 12.78B | 7.64B |
| Depreciation & Amortization | 8.73B | 5.48B | 5.26B | 6.21B | 6.37B | 4.61B | 4.68B | 3.20B | 2.03B | 1.37B | 1.08B | 901.81M | 856.55M | 33.82B | 32.91B | 28.20B | 20.65B |
| EBITDA | 81.98B | 42.83B | 56.17B | 30.52B | 21.70B | 9.37B | 39.31B | 23.50B | 149.10B | 10.66B | 7.90B | 6.09B | 5.71B | 42.61B | 110.58B | 134.88B | 102.52B |
| EBITDA Ratio | 6.57% | 8.09% | 6.11% | 4.48% | 5.44% | 3.63% | 6.02% | 3.53% | 30.71% | 4.32% | 5.86% | 77.21% | 33.94% | 6.44% | 18.02% | 10.91% | 19.29% |
| Operating Income | 124.47B | 67.63B | 58.85B | 32.50B | 37.99B | 26.16B | 39.07B | 28.65B | 216.42B | 17.47B | 11.19B | 4.15B | 4.41B | 9.45B | 72.99B | 81.69B | 80.81B |
| Operating Income Ratio | 9.97% | 6.46% | 6.19% | 3.79% | 4.65% | 3.69% | 5.99% | 4.31% | 27.88% | 3.28% | 5.09% | 21.11% | 26.25% | 1.47% | 10.58% | 13.46% | 15.21% |
| Total Other Income/Expenses | 6.07B | 5.55B | -9.73B | -2.54B | 11.93B | 2.28B | 13.87B | 33.02M | 83.15B | 1.20B | 1.32B | -348.70M | -478.71M | -15.91B | -10.57B | 12.21B | -1.63B |
| Income Before Tax | 130.54B | 73.18B | 49.12B | 29.97B | 35.43B | 18.82B | 33.40B | 18.91B | 233.73B | 18.67B | 10.45B | 12.85B | 3.94B | -6.46B | 62.42B | 93.90B | 79.18B |
| Income Before Tax Ratio | 10.46% | 7.00% | 5.17% | 3.50% | 4.34% | 2.66% | 5.12% | 2.84% | 30.11% | 3.51% | 4.75% | 65.43% | 23.41% | -1.01% | 9.05% | 15.47% | 14.90% |
| Income Tax Expense | 15.42B | 4.14B | 6.18B | 7.37B | 4.69B | 798.29M | 2.58B | 10.97B | 56.28B | -3.19B | 851.58M | 372.87M | 18.62B | -7.34B | 6.13B | 18.60B | 23.36B |
| Net Income | 115.12B | 69.21B | 42.94B | 22.60B | 30.74B | 18.02B | 30.07B | 7.94B | 178.52B | 21.31B | 9.58B | 12.48B | -14.69B | 5.98B | 50.53B | 71.55B | 53.00B |
| Net Income Ratio | 9.23% | 6.62% | 4.52% | 2.64% | 3.76% | 2.55% | 4.61% | 1.19% | 23.00% | 4.00% | 4.36% | 63.52% | -87.38% | 0.93% | 7.32% | 11.79% | 9.97% |
| EPS | 1.69K | 1.01K | 625.80 | 329.31 | 456.81 | 268.09 | 450.15 | 116.18 | 2.63K | 307.54 | 134.05 | 174.16 | -222.62 | 112.59 | 3.13K | 4.36K | 3.38K |
| EPS Diluted | 1.69K | 1.01K | 625.80 | 329.31 | 456.81 | 262.37 | 450.15 | 116.18 | 2.63K | 307.54 | 134.05 | 174.16 | -222.62 | 112.59 | 3.13K | 4.36K | 3.38K |
| Weighted Avg Shares Out | 67.96M | 68.49M | 68.62M | 68.63M | 67.30M | 67.22M | 66.80M | 68.28M | 67.89M | 69.30M | 71.45M | 71.65M | 65.99M | 53.09M | 16.15M | 16.42M | 15.67M |
| Weighted Avg Shares Out (Dil) | 67.96M | 68.49M | 68.62M | 68.63M | 67.30M | 68.68M | 66.80M | 68.32M | 67.90M | 69.30M | 71.45M | 71.65M | 65.99M | 53.09M | 16.15M | 16.42M | 15.67M |
Source: https://incomestatements.info
Category: Stock Reports